Hence, TIM4 blockade abrogates this sequestration and proliferation suppression and enhances anti-tumor efficacy in models of anti-PD-1 therapy and adoptive T cell therapy in mice (Chow et al., 2021). The gene discussed is TIMD4; the disease is neoplasm.